VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $229,300 | -45.1% | 7,615 | -41.0% | 0.02% | -48.9% |
| Q1 2023 | $417,814 | -75.7% | 12,915 | -73.0% | 0.05% | -60.5% |
| Q2 2021 | $1,721,000 | 0.0% | 47,791 | 0.0% | 0.12% | -51.2% |
| Q4 2020 | $1,721,000 | -0.3% | 47,791 | +8.4% | 0.24% | -23.5% |
| Q3 2020 | $1,726,000 | +126.8% | 44,069 | +112.4% | 0.32% | +89.9% |
| Q2 2020 | $761,000 | -76.0% | 20,750 | -85.3% | 0.17% | -76.2% |
| Q1 2019 | $3,173,000 | – | 141,522 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |